Clinical Trial

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

Study acronym: ROCK-RT
Recruiting
View on ClinicalTrials.gov →
Summary
This observational study will investigate the properties of image files standardly collected during radiation therapy treatment in a cross-section of liver cancer patients who received stereotactic ablative body radiation therapy (SABR) after trans-catheter arterial chemo emobilisation (TACE). Specifically, it will determine whether the radio-opaque contrast agents in the image files can be detected by tumour-tracking software (KIM).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-12-08; most recent amendment 2026-05-15.
Status change: Not Yet Recruiting → Recruiting 2023-06-20
Trial Details
NCT Number NCT05169177
Lead Sponsor University of Sydney
Collaborators: Calvary Mater Newcastle, Australia, Western Sydney Local Health District, Austin Health, Peter MacCallum Cancer Centre, Australia, Princess Alexandra Hospital, Brisbane, Australia
Conditions Liver Neoplasm
Enrollment 50 participants
Start Date 2022-10-17
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19